Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.1K

Targeting mitochondrial complexes for cancer therapy

Alaa M A Osman1, Alya A Arabi1

  • 1College of Medicine and Health Sciences, Department of Biochemistry and Molecular Biology, United Arab Emirates University, AlAin P. O. Box: 15551, United Arab Emirates.

Biochemical Pharmacology
|January 12, 2026
PubMed

Insights

Targeting mitochondrial electron transport chain (ETC) complexes offers a novel strategy for cancer therapy by disrupting cancer cell energy production. This review explores ETC inhibition, bioenergetic disruption, and advanced therapeutic approaches, including AI and nanomedicine.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Mitochondrial electron transport chain (ETC) complexes I-IV are crucial for cancer cell energy and biosynthesis.
  • Inhibiting these complexes is a promising strategy to block cancer cell survival.

Purpose of the Study:

  • To review current findings on ETC complex inhibition for cancer treatment.
  • To explore bioenergetic disruption and novel therapeutic strategies like photodynamic therapy (PDT).
  • To highlight the role of AI and nanotechnologies in developing ETC-targeted cancer drugs.

Main Methods:

  • In silico, in vitro, and in vivo studies on ETC complex inhibition were reviewed.
  • Analysis of bioenergetic disruption mechanisms.
  • Exploration of therapeutic strategies including PDT, small molecules, repurposed drugs, AI, and nanotechnologies.

Main Results:

  • Inhibition of ETC complexes effectively blocks cancer cell survival.
  • Photodynamic therapy (PDT) and other novel strategies show promise.
  • AI and nanotechnologies can accelerate the discovery of ETC-targeted anticancer drugs.
  • Targeting ETC complexes can be integrated into precision medicine.

Conclusions:

  • Mitochondrial ETC complexes are viable targets for developing novel anticancer drugs.
  • A combination of bioenergetic disruption, innovative therapies, and AI-driven approaches can enhance cancer treatment.
  • Precision medicine strategies can leverage ETC dependencies for personalized cancer therapy.
Keywords:
CancerDrug discoveryElectron transport chainMitochondriaOxidative phosphorylation

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

7.4K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.4K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K